We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Preoperative In-Vitro Platelet Function Tests Investigated

By LabMedica International staff writers
Posted on 11 Nov 2016
Print article
Image: The STA-R automatic coagulation analyzer (Photo courtesy of Diagnostica Stago).
Image: The STA-R automatic coagulation analyzer (Photo courtesy of Diagnostica Stago).
It is essential to predict the bleeding risk in patients undergoing functional endoscopic sinus surgery (FESS) and to evaluate the adequacy of primary hemostasis, preoperative hemostatic screening tests are used.

Operation without any hemostatic screening test results may lead to increased morbidity and mortality. In addition, perioperative hemorrhage may require the administration of blood products to correct a deficit of red blood cells or underlying or resulting coagulopathy. The risks of blood transfusion also cause increased morbidity and mortality.

Medical scientists at the Catholic University of Daegu School of Medicine (Daegu, Republic of Korea) reviewed the medical records of 90 patients without bleeding histories that had undergone FESS from March 2013 to June 2014. More than 200 mL of blood loss was defined as moderate bleeding during surgery. With respect to bleeding during surgery, they determined the sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) of collagen/epinephrine (CT-epi), prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT) and bleeding during FESS.

The patient population was classified into prolonged and normal groups according to the laboratory results of CT-epi (PFA-100), PT, INR and aPTT (STA-R analyzer, Diagnostica Stago, Asnières Sur Seine, France). All CT-epi values greater than 192 seconds, PT value greater than 15.0 seconds, INR values greater than 1.2 and aPTT values greater than 45.0 seconds were defined as prolonged, and all results below these values were defined as normal.

Of the 90 patients, 17 (18.9%) patients had preoperative prolonged CT values and three (17.6%) patients had bleeding. In comparison, five (6.8%) of the 73 (81.1%) patients who had undergone FESS with preoperative normal PFA values experienced bleeding. On the other hand, the two patients with prolonged PT values and the three with prolonged INR values or the one with prolonged with PTT values had no bleeding episode. Preoperative CT had low sensitivity (44.4%) and PPV (23.5%).

The authors concluded that during preoperative period, the hemostatic screening may not be helpful to detect the bleeding tendency in adult patients undergoing FESS. Routine measurement of CT-epi, PT, INR and aPTT for preoperative screening may not be recommended for FESS patients. The study was published on October 21, 2016, in the Journal of Blood Medicine.

Related Links:
Catholic University of Daegu School of Medicine
Diagnostica Stago
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more